NCT02507245View on ClinicalTrials.gov

Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)

CompletedOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

May 31, 2015

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Growth Hormone-Releasing Hormone

From Baseline Visit (T0) to 6th Month Visit 0,025 mg/kg Growth Hormone/die. From 6th Month Visit to 12th Month Visit 0,030 mg/Kg Growth Hormone/die.

All Listed Sponsors
lead

Stefania La Grutta, MD

OTHER

NCT02507245 - Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD) | Biotech Hunter | Biotech Hunter